Lucerna, Inc.

At Lucerna, we are developing new sets of research tools to study and exploit RNA the same way fluorescent proteins did for the protein field. Lucerna Team: Karen Wu

Read More

Mirimus

Mirimus is engaged in the design, development and pioneering of new genome editing technologies to develop animal models that are crucial for the preclinical evaluation of new therapeutics. Mirimus Team: Prem Premsrirut    

Read More

CMP Scientific

CMP Scientific, Corp. is an analytical instrumentation company that provides capillary electrophoresis – mass spectrometry coupling interfaces to support therapeutics analysis for global biopharmaceutical companies. CMP Scientific Team: James Xia   CMP Scientific was with The Next Milestone at the Downstate Incubator from 2016 to 2017.

Read More

Unicrobe

We will provide bacterial genome editing services using CRISPR-Cas technologies for academic and industrial customers interested in improving human health and developing bacterial technologies. Team: Wenyan Jiang – CEO, CSO Yuchen Qi – Business Development

Read More

iLight Biotechnologies

Genetic tools for non-invasive activation and detection of biological processes with deeply penetrating near-infrared light that will make drug discovery process more efficient. iLight Biotechnologies Team: Daria Shcherbakova, PhD. – Co-founder, CEO Vladislav Verkhusha, PhD. – Co-founder, CSO

Read More

MouSensor, Inc.

MouSensors provide the first genetic platform for smell pharmacology to assist humans in scent detection tasks such as non-invasive cancer diagnosis, Tuberculosis identification, explosives detection etc. Team: Paul Feinstein, PhD. – Co-founder Charlotte D’Hulst, PhD. – Co-founder

Read More

AIdentyfy

AIdentyfy is a healthcare software company that offers machine learning-based digital solutions that have been developed by physicians for physicians. Team: Samuel K. Cho, MD Eric K. Oermann, MD Jun S. Kim, MD

Read More

Lipidsense

LipidSense is developing an optical sensor to non-invasively monitor lipid accumulation in live animals for accelerating pre-clinical drug development. Team: Prakrit Jena, PhD. – Co-founder, CEO Daniel Heller, PhD. – Co-founder

Read More